ArticleNeuron2019

Loss of Adaptive Myelination Contributes to Methotrexate Chemotherapy-Related Cognitive Impairment.

Anna C Geraghty et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.